Research outputs

Selected research outputs

Acinetobacter baumannii transformants expressing oxacillinases and metallo-β-lactamases that confer resistance to meropenem: new tools for anti-Acinetobacter drug development and AMR preparedness (Journal article - 2024)
Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by Pseudomonas aeruginosa (Journal article - 2024)
Targeting Superoxide Dismutase Confers Enhanced Reactive Oxygen Species-Mediated Eradication of Polymyxin B-Induced Acinetobacter baumannii Persisters (Journal article - 2023)
Disulfiram enhances meropenem activity against NDM- and IMP-producing carbapenem-resistant Acinetobacter baumannii infections (Journal article - 2022)
The unusual glycine-rich C terminus of the Acinetobacter baumannii RNA chaperone Hfq plays an important role in bacterial physiology (Journal article - 2018)

Filter research outputs

What type of research output do you want to show?

All

Journal

Preprint

2026

Genotypic-phenotypic discordance for cefiderocol against Enterobacter hormaechei.

Dubey, V., Gerada, A., Jones, C. M., Cruise, J., Hope, W., & Howard, A. (2026). Genotypic-phenotypic discordance for cefiderocol against Enterobacter hormaechei.. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 108479. doi:10.1016/j.ijid.2026.108479

DOI: 10.1016/j.ijid.2026.108479
: Journal article

2025

Antimicrobial use and resistance

Reza, N., Dubey, V., Sharland, M., & Hope, W. (2025). Antimicrobial use and resistance. BMJ-BRITISH MEDICAL JOURNAL, 391. doi:10.1136/bmj-2024-082681

DOI: 10.1136/bmj-2024-082681
: Journal article

Molecular pharmacodynamics of amoxicillin-clavulanic acid against Escherichia coli

DOI: 10.21203/rs.3.rs-8148425/v1
: Preprint

Drug-resistant Acinetobacter baumannii: mortality, emerging treatments, and future pharmacological targets for a WHO priority pathogen

Dubey, V., Reza, N., & Hope, W. (2025). Drug-resistant Acinetobacter baumannii: mortality, emerging treatments, and future pharmacological targets for a WHO priority pathogen. CLINICAL MICROBIOLOGY REVIEWS, 38(3). doi:10.1128/cmr.00279-24

DOI: 10.1128/cmr.00279-24
: Journal article

Combining antibiotics to tackle antimicrobial resistance (vol 10, pg 813, 2025)

Hope, W., Nambiar, S., O'Brien, S., Sharland, M., Paterson, D. L., Yin, M., . . . Howard, A. (2025). Combining antibiotics to tackle antimicrobial resistance (vol 10, pg 813, 2025). NATURE MICROBIOLOGY, 10(5), 1258. doi:10.1038/s41564-025-02003-w

DOI: 10.1038/s41564-025-02003-w
: Journal article

Combining antibiotics to tackle antimicrobial resistance

Hope, W., Nambiar, S., O'Brien, S., Sharland, M., Paterson, D. L., Yin, M., . . . Howard, A. (2025). Combining antibiotics to tackle antimicrobial resistance. NATURE MICROBIOLOGY, 10(4), 813-816. doi:10.1038/s41564-025-01969-x

DOI: 10.1038/s41564-025-01969-x
: Journal article

Cefepime/Enmetazobactam: a microbiological, pharmacokinetic, pharmacodynamic, and clinical evaluation

Darlow, C. A., Hope, W., & Dubey, V. (2025). Cefepime/Enmetazobactam: a microbiological, pharmacokinetic, pharmacodynamic, and clinical evaluation. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 21(2), 115-123. doi:10.1080/17425255.2024.2427310

DOI: 10.1080/17425255.2024.2427310
: Journal article

2024

Susceptibility of OXA-48-like-producing Enterobacterales to flomoxef

Owen, V., Harper, N., Dubey, V., Gerada, A., Boyd, S. E., & Darlow, C. A. (2024). Susceptibility of OXA-48-like-producing Enterobacterales to flomoxef. CLINICAL MICROBIOLOGY AND INFECTION, 30(12), 1606-1608. doi:10.1016/j.cmi.2024.07.017

DOI: 10.1016/j.cmi.2024.07.017
: Journal article

Acinetobacter baumannii transformants expressing oxacillinases and metallo-β-lactamases that confer resistance to meropenem: new tools for anti-Acinetobacter drug development and AMR preparedness

Dubey, V., Farrington, N., Harper, N., Johnson, A., Horner, I., Stevenson, A., . . . Hope, W. (2024). Acinetobacter baumannii transformants expressing oxacillinases and metallo-β-lactamases that confer resistance to meropenem: new tools for anti-Acinetobacter drug development and AMR preparedness. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 68(10). doi:10.1128/aac.00222-24

DOI: 10.1128/aac.00222-24
: Journal article

Decoding Bacterial Persistence: Mechanisms and Strategies for Effective Eradication

Sett, A., Dubey, V., Bhowmik, S., & Pathania, R. (2024). Decoding Bacterial Persistence: Mechanisms and Strategies for Effective Eradication. ACS INFECTIOUS DISEASES, 10(8), 2525-2539. doi:10.1021/acsinfecdis.4c00270

DOI: 10.1021/acsinfecdis.4c00270
: Journal article

Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by Pseudomonas aeruginosa

Farrington, N., Dubey, V., Johnson, A., Horner, I., Stevenson, A., Unsworth, J., . . . Wright, G. D. (2024). Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by Pseudomonas aeruginosa. MBIO, 15(2). doi:10.1128/mbio.03165-23

DOI: 10.1128/mbio.03165-23
: Journal article

2023

Targeting Superoxide Dismutase Confers Enhanced Reactive Oxygen Species-Mediated Eradication of Polymyxin B-Induced Acinetobacter baumannii Persisters

Dubey, V., Gupta, R., & Pathania, R. (2021). Targeting Superoxide Dismutase Confers Enhanced Reactive Oxygen Species-Mediated Eradication of Polymyxin B-Induced Acinetobacter baumannii Persisters. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 65(5). doi:10.1128/AAC.02180-20

DOI: 10.1128/AAC.02180-20
: Journal article

2022

Disulfiram enhances meropenem activity against NDM- and IMP-producing carbapenem-resistant Acinetobacter baumannii infections

Dubey, V., Devnath, K., Gupta, V. K., Kalyan, G., Singh, M., Kothari, A., . . . Pathania, R. (2022). Disulfiram enhances meropenem activity against NDM- and IMP-producing carbapenem-resistant Acinetobacter baumannii infections. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 77(5), 1313-1323. doi:10.1093/jac/dkac057

DOI: 10.1093/jac/dkac057
: Journal article

2019

Biofilms in Antimicrobial Activity and Drug Resistance

Bhando, T., Dubey, V., & Pathania, R. (2019). Biofilms in Antimicrobial Activity and Drug Resistance. Unknown Journal, 109-139. doi:10.1007/978-981-13-8503-2_6

DOI: 10.1007/978-981-13-8503-2_6
: Journal article

Computational Prediction of sRNA in Acinetobacter baumannii

Arya, S., Dubey, V., Sen, D., Sharma, A., & Pathania, R. (2019). Computational Prediction of sRNA in Acinetobacter baumannii. ACINETOBACTER BAUMANNII, 1946, 307-320. doi:10.1007/978-1-4939-9118-1_27

DOI: 10.1007/978-1-4939-9118-1_27
: Journal article

2018

The unusual glycine-rich C terminus of the Acinetobacter baumannii RNA chaperone Hfq plays an important role in bacterial physiology

Sharma, A., Dubey, V., Sharma, R., Devnath, K., Gupta, V. K., Akhter, J., . . . Pathania, R. (2018). The unusual glycine-rich C terminus of the Acinetobacter baumannii RNA chaperone Hfq plays an important role in bacterial physiology. JOURNAL OF BIOLOGICAL CHEMISTRY, 293(35), 13377-13388. doi:10.1074/jbc.RA118.002921

DOI: 10.1074/jbc.RA118.002921
: Journal article

Dr Vineet Dubey
BTech, PhD